Detalhe da pesquisa
1.
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study.
Lancet Oncol
; 24(10): 1119-1133, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37717583
2.
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk.
Int J Cancer
; 152(2): 239-248, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36082445
3.
Geographical and ecological analyses of multiple myeloma in Denmark: Identification of potential hotspot areas and impact of urbanisation.
Eur J Haematol
; 110(3): 289-295, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36413106
4.
Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries.
Eur J Haematol
; 108(2): 99-108, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34514635
5.
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group.
Eur J Haematol
; 108(1): 34-44, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34536308
6.
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients.
Int J Cancer
; 149(2): 327-336, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33675538
7.
Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival.
Int J Cancer
; 148(8): 1887-1894, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152124
8.
Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population-based study from the Danish national multiple myeloma registry.
Br J Haematol
; 193(1): 119-124, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32515050
9.
2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde.
Haematologica
; 106(11): 2799-2812, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34261295
10.
Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.
Hematol Oncol
; 39(4): 521-528, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34342035
11.
Clarithromycin added to bortezomib-cyclophosphamide-dexamethasone impairs health-related quality of life in multiple myeloma patients.
Eur J Haematol
; 102(1): 70-78, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30230047
12.
Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients.
Br J Haematol
; 183(3): 375-384, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30079960
13.
The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy.
Am J Hematol
; 97(3): E117-E120, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34967035
14.
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length.
Int J Cancer
; 136(5): E351-8, 2015 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25066524
15.
GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis.
Support Care Cancer
; 23(3): 841-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25218607
16.
The real-world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodies.
EJHaem
; 4(4): 1006-1012, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38024635
17.
Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation.
Leukemia
; 37(10): 2107-2114, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37568010
18.
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN).
Leukemia
; 37(6): 1175-1185, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142661
19.
A polygenic risk score for multiple myeloma risk prediction.
Eur J Hum Genet
; 30(4): 474-479, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34845334
20.
Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?
Cancer Epidemiol Biomarkers Prev
; 31(9): 1863-1866, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35700034